Back
The Descartes Systems Group, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
77
DSGX
The Descartes Systems Group, Inc.
Last Price:
$93.43
Seasonality Move:
23.6%
Buy
67
GPCR
Structure Therapeutics, Inc.
Last Price:
$68.85
Seasonality Move:
-31.39%
Buy
77
The Descartes Systems Group, Inc. (DSGX)
is a Buy
Is The Descartes Systems Group, Inc. a Buy, Sell or Hold?
-
The current The Descartes Systems Group, Inc. [DSGX] share price is $91.79. The Score for DSGX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
DSGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $66.74. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DSGX Stock Price Chart
What is The Descartes Systems Group, Inc.'s stock price today?
-
The The Descartes Systems Group, Inc. share price today is $91.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $66.74Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
DSGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 61.78 | Buy |
| Chaikin Money Flow: | -310556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.4 | Buy |
| Relative Strength Index (14 RSI): | 80.52 | Buy |
| Chaikin Money Flow: | -2951117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DSGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 87.71 | Buy |
| 20-day SMA: | 84.03 | Buy |
| 50-day SMA: | 89.38 | Buy |
| 200-day SMA: | 100.2 | Sell |
| 8-day EMA: | 88.84 | Buy |
| 20-day EMA: | 86.62 | Buy |
| 50-day EMA: | 89.26 | Buy |
| 200-day EMA: | 97.98 | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.28 | Buy |
| 20-day SMA: | 38.08 | Buy |
| 50-day SMA: | 32.93 | Buy |
| 200-day SMA: | 23.94 | Buy |
| 8-day EMA: | 47.33 | Buy |
| 20-day EMA: | 39.93 | Buy |
| 50-day EMA: | 33.93 | Buy |
| 200-day EMA: | 27.69 | Buy |
The Descartes Systems Group, Inc. Earnings Growth & DSGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.62 per share, and an increase next year of $0.26 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.14 per share.
The Descartes Systems Group, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||